Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

Borkenstein, M.
The effects of intranasal insufflation of growth hormone releasing factor analogue GRF 1-29 NH2 on growth hormone secretion in children with short stature.
Acta Endocrinol Suppl (Copenh). 1986; 279(24):135-138 Doi: 10.1530/acta.0.112S135
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Leading authors Med Uni Graz
Borkenstein Helmuth Martin
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
The effects of intranasal insufflation of the synthetic growth hormone releasing factor GRF 1-29-NH2 on serum growth hormone (GH) were investigated in five healthy prepubertal children with short stature. 100 micrograms/kg/body weight of synthetic GRF 1-29-NH2, 500 micrograms in 100 microliters water, were insufflated intranasally after careful cleaning of the nose. GRF 1-29-NH2 induced a prompt rise of serum GH levels with peak values at 15 minutes in all children investigated. Peak serum GH values were 28.3 +/- 12.0 ng/ml (mean +/- SD), range 17.1 - 47.6 ng/ml; delta GH was 27.0 +/- 12.2 ng/ml (mean +/- SD). Serum GH levels were still significantly raised 120 minutes after the insufflation of GRF 1-29-NH2 (p less than 0.05). No side effects, except for burning of the nasal mucosa in one patient, were observed. The results of this study demonstrate that intranasal insufflation of synthetic GRF 1-29-NH2 induces a prompt release of GH in otherwise normal children with short stature. Pulsatile intranasal insufflation of GRF 1-29-NH2 probably could be used for the treatment of some children with GH deficiency due to a defect at a suprapituitary level.
Find related publications in this database (using NLM MeSH Indexing)
Administration, Intranasal -
Child -
Child, Preschool -
Female -
Growth Disorders - drug therapy Growth Disorders - physiopathology
Growth Hormone - secretion
Growth Hormone-Releasing Hormone - administration & dosage Growth Hormone-Releasing Hormone - adverse effects Growth Hormone-Releasing Hormone - therapeutic use
Humans -
Kinetics -
Male -
Peptide Fragments - administration & dosage Peptide Fragments - adverse effects Peptide Fragments - therapeutic use
Sermorelin -

© Med Uni GrazImprint